News

Scripps Research scientists discover that some membrane-less compartments are built from tiny filaments—a finding that could shape drug development.

Scripps Research and UC San Diego scientists used a novel method to show that some memory neurons produce proteins at higher rates than others.

Partnering to speed up the discovery of new malaria drugs that target parasite cytoskeletal pathways, with a focus on global access and affordability.

Irvine is recognized for his work in empowering the immune system to fight disease, which includes enhancing vaccines against HIV and cancer. 

Modified molecule shows diminished respiratory depression—the leading cause of opioid overdose deaths—while retaining full pain-blocking capability.

Scripps Research scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.

Measuring membrane thickness was previously only possible in artificial membranes—now scientists can do it inside intact cells, providing crucial context for understanding how cells work.

How consumers’ digital activity trackers could enable personalized health screening and early intervention for cardiovascular health and beyond.

Experiments show how dependence on alcohol rewires the brain's "go" and "stop drinking" signaling systems, with implications for preventing relapse.

Scripps Research scientists developed a technique that maps drug binding in individual cells throughout the body, potentially explaining side effects and guiding safer drug development.

“Tiny biological batteries” can change the cell membrane’s electrical properties—a discovery that has big implications for health, as many essential cellular processes hinge upon precise electrical activity.

Scripps Research scientists identify the protein that helps kidney cells regulate renin, providing foundational insight into how kidneys function.

Scripps Research scientists turn nanoparticles into virus “showcases” to help the immune system recognize deadly threats.

Scripps Research scientists find that certain gut bacteria are essential for building immune defenses during infancy, pointing to new strategies for protecting children’s health.

A new method uses a novel catalyst and inexpensive fluoride salts to modify the most common chemical bonds—opening doors to new medicines and improved medical imaging.

A Scripps Research-led study resolves the challenge of synthesizing saxitoxin, paving the way for new possibilities in pain management.

New findings from Scripps Research reveal how certain tumors survive DNA damage—and point to a strategy for targeting them.

New AI system helps scientists rapidly pinpoint the most promising paths to an HIV vaccine.

Molecular insights could lead to improved labor and pain treatments.

The recognized researchers encompass various areas including chemistry, microbiology, immunology, biochemistry and more.

Study reveals how sugar-protein interactions are critical for the placenta during early pregnancy, shedding light on complications like preeclampsia and restricted fetal growth.

Finance and biomedical leaders bring decades of experience in investment strategy and drug development.

The funding will support a multidisciplinary collaboration of four Scripps Research scientists to identify more effective vaccines to treat HIV.

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.